Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
9.70
-0.54 (-5.27%)
At close: Sep 24, 2026, 4:00 PM EDT
9.90
+0.20 (2.06%)
After-hours: Sep 24, 2026, 7:52 PM EDT
TNXP Market Cap
TNXP has a market cap or net worth of $166.36 million as of September 24, 2026. Its market cap has decreased by -24.96% in one year.
Market Cap
166.36M
Enterprise Value
-8.60M
1-Year Change
-24.96%
Ranking
Category
Stock Price
$9.70
ChartMarket Cap Chart
Since July 16, 2019, TNXP's market cap has increased from $7.29M to $166.36M, an increase of 2,180.95%. That is a compound annual growth rate of 54.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 166.36M | -14.05% |
| Dec 31, 2025 | 193.56M | 214.02% |
| Dec 31, 2024 | 61.64M | 160.94% |
| Dec 29, 2023 | 23.62M | 5.35% |
| Dec 30, 2022 | 22.42M | -87.36% |
| Dec 31, 2021 | 177.42M | 37.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oramed Pharmaceuticals | 198.42M |
| Canton Strategic Holdings | 198.41M |
| Acumen Pharmaceuticals | 195.26M |
| Satellos Bioscience | 194.74M |
| Precision BioSciences | 194.59M |
| Voyager Therapeutics | 191.94M |
| Alpha Cognition | 191.75M |
| YD Bio | 186.99M |